It’s always inspiring to see
the implementation of local cutting-edge medical practice and research
that can have implications for the wider world. Aspetar, the sports
medicine hospital in Doha, is a leader in its field regionally and
internationally, attracting some of the world’s top sports men and
women to its facility for treatment. The hospital continues to innovate.
In this issue, Middle East Health reports on one of their new initiatives
– the athlete injury and illness prevention programme (ASPREV).
As well as providing a comprehensive screening programme for athletes
in Doha, a core component of ASPREV is a longterm prospective cohort
study designed to identify risk factors for injury and illness in
athletes and then to develop prevention strategies to reduce the
injury and illness incidence. This is an exciting project that is
set to impact sports men and women locally and around the world.
You can read the report on page 28.
Also in this issue we publish a report analysing the health status
of the United Arab Emirates. A team of researchers look at the ‘big
4’ public health issues. Surprisingly ‘injury’ ranks second, being
responsible for 17% of mortality in all age groups in 2010. Read
the report on page 46.
German companies developing products for the medical industry continue
to lead the field when it comes to innovation and quality. Add to
this the close co-operation between companies and scientific research
facilities and it’s not difficult to see why they remain so strong
and competitive in the global marketplace. The German report in
this issue looks at some of the key factors that enable Germany
to dominate the European healthcare market and why their products
will always be sought after. The report is on page 34.
Elsewhere in this issue we look at the latest developments in the
deadly Middle East Respiratory Syndrome and researchers’ struggle
to find the source of the coronavirus; we also look at the latest
World Health Report published by the World Health Organisation in
August, which calls for increased local health research in an effort
to improve the provision of public health; and staying with the
WHO, we look at a report the organisation released recently which
provides new data on the leading causes of death globally. Cardiovascular
diseases remain the number one killer, however, tuberculosis is
no longer in the top 10.
I trust you will enjoy this issue and find the articles informative
Brian Wilkie Publisher